Kestra Medical Technologies, Ltd. Common Stock Cash Flow Conversion Efficiency
Kestra Medical Technologies, Ltd. Common Stock cash flow conversion efficiency. Based on the latest financial reports, Kestra Medical Technologies, Ltd. Common Stock (KMTS) has a cash flow conversion efficiency ratio of -0.064x as of January 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-18.37 Million) by net assets ($287.99 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Kestra Medical Technologies, Ltd. Common Stock (2020–2025)
Cash flow conversion efficiency of Kestra Medical Technologies, Ltd. Common Stock from 2020 to 2025. This chart illustrates how Kestra Medical Technologies, Ltd. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Kestra Medical Technologies, Ltd. Common stock price today for real-time trading data and today's change.
Kestra Medical Technologies, Ltd. Common Stock Cash Flow Conversion Ratio Explained
Kestra Medical Technologies, Ltd. Common Stock cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Kestra Medical Technologies, Ltd. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kestra Medical Technologies, Ltd. Common Stock ranked by their cash flow conversion efficiency. Also see how much is Kestra Medical Technologies, Ltd. Common worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Adriatic Metals Plc
F:3FN
|
-0.035x |
|
Capital Clean Energy Carriers Corp.
NASDAQ:CCEC
|
0.040x |
|
Berkshire Hills Bancorp Inc
NYSE:BHLB
|
0.032x |
|
Nutex Health Inc
NASDAQ:NUTX
|
0.067x |
|
Global Brands Manufacture Ltd
TW:6191
|
0.059x |
|
Uniti Group Inc
NASDAQ:UNIT
|
0.711x |
|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
-0.181x |
|
Hainan Haide Industry Co Ltd
SHE:000567
|
-0.099x |
Annual Cash Flow Conversion Efficiency for Kestra Medical Technologies, Ltd. Common Stock (2020–2025)
The table below shows the annual cash flow conversion efficiency of Kestra Medical Technologies, Ltd. Common Stock from 2020 to 2025. Review Kestra Medical Technologies, Ltd. Common free cash flow to debt ratio to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-04-30 | $205.41 Million | $-77.61 Million | -0.378x | -209.52% |
| 2024-04-30 | $-209.38 Million | $-72.23 Million | 0.345x | -41.75% |
| 2023-04-30 | $-117.58 Million | $-69.64 Million | 0.592x | +103.50% |
| 2021-04-30 | $1.77 Million | $-29.89 Million | -16.928x | -115.53% |
| 2020-04-30 | $3.86 Million | $-30.29 Million | -7.854x | -- |
About Kestra Medical Technologies, Ltd. Common Stock
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, thera… Read more